ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
2.48
-0.16
(-6.06%)
Closed December 24 4:00PM
2.48
0.00
(0.00%)
After Hours: 5:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.48
Bid
2.41
Ask
2.59
Volume
20,644
2.47 Day's Range 2.62
0.50 52 Week Range 4.95
Market Cap
Previous Close
2.64
Open
2.62
Last Trade
20
@
2.46
Last Trade Time
Financial Volume
$ 51,663
VWAP
2.5026
Average Volume (3m)
102,247
Shares Outstanding
112,824,183
Dividend Yield
-
PE Ratio
6.58
Earnings Per Share (EPS)
0.38
Revenue
409.92M
Net Profit
42.54M

About Procaps Group SA

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardio... Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. Show more

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Headquarters
Luxembourg City, Luxembourg, Lux
Founded
-
Procaps Group SA is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker PROC. The last closing price for Procaps was $2.64. Over the last year, Procaps shares have traded in a share price range of $ 0.50 to $ 4.95.

Procaps currently has 112,824,183 shares outstanding. The market capitalization of Procaps is $297.86 million. Procaps has a price to earnings ratio (PE ratio) of 6.58.

PROC Latest News

Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates

MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Group Announces Financing, Shareholders Agreement and Board Updates

MIAMI and BARRANQUILLA, Colombia , Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today that, on November 13, 2024, the Company...

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Issues Shareholder Letter

MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical...

Procaps Group Announces New Chairman

Ruben Minski decides to step down as Executive Chairman and José Minski is appointed as new Chairman of the Board Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

Procaps Group (Nasdaq: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has received a letter from the Nasdaq...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it has determined it is unable to file...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.79-24.15902140673.273.7752.4737292.90366525CS
41.28106.6666666671.23.7751.1614999272.24771184CS
120.2712.21719457012.213.7750.51022471.49862736CS
26-0.22-8.148148148152.73.7750.5499751.53251972CS
52-0.98-28.3236994223.464.950.5329771.99417947CS
156-6.76-73.16017316029.2410.20.5271774.3516885CS
260-5.93-70.51129607618.4111.980.5323125.55375647CS

PROC - Frequently Asked Questions (FAQ)

What is the current Procaps share price?
The current share price of Procaps is $ 2.48
How many Procaps shares are in issue?
Procaps has 112,824,183 shares in issue
What is the market cap of Procaps?
The market capitalisation of Procaps is USD 297.86M
What is the 1 year trading range for Procaps share price?
Procaps has traded in the range of $ 0.50 to $ 4.95 during the past year
What is the PE ratio of Procaps?
The price to earnings ratio of Procaps is 6.58
What is the cash to sales ratio of Procaps?
The cash to sales ratio of Procaps is 0.68
What is the reporting currency for Procaps?
Procaps reports financial results in USD
What is the latest annual turnover for Procaps?
The latest annual turnover of Procaps is USD 409.92M
What is the latest annual profit for Procaps?
The latest annual profit of Procaps is USD 42.54M
What is the registered address of Procaps?
The registered address for Procaps is 9, RUE DE BITBOURG, LUXEMBOURG CITY, LUXEMBOURG, L-1273
What is the Procaps website address?
The website address for Procaps is www.procapsgroup.com
Which industry sector does Procaps operate in?
Procaps operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BAOSBaosheng Media Group Holdings Ltd
$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
$ 11.35
(3.56%)
108.38M

PROC Discussion

View Posts
No Posts Found

Your Recent History

Delayed Upgrade Clock